Skip to main content
Premium Trial:

Request an Annual Quote

Amersham to Distribute InforMax Software in Latin America

SAN DIEGO, Oct. 26 – Amersham Biosciences has agreed to distribute InforMax’s desktop software in Latin America, the companies announced Friday.

In the exclusive distribution agreement, Piscataway, NJ-based Amersham will distribute InforMax’s Vector NTI Suite molecular biology software in Brazil, Argentina, Bolivia, Guyana, Colombia, Peru, Surinam, French Guiana, Chile, Nicaragua, Venezuela, Ecuador, Uruguay, Paraguay, Mexico, Panama, El Salvador, Honduras, Guatemala, Costa Rica, and all Caribbean countries except Cuba. 

Financial details of the agreement were not disclosed.

“Amersham Biosciences' leadership position in Latin America will be instrumental in expanding our customer base in those countries,” Alex Titomirov, CEO of Bethesda, Md.-based InforMax, said in a statement.

Last week, InforMax announced major changes in its leadership , including Titomirov, who is also chairman of InforMax’s board, stepping down from his CEO position upon the hiring of a replacement.

Amersham Biosciences, which last week was renamed from its former name Amersham Pharmacia Biotech , owns an equity stake in InforMax as part of a September 2000 collaboration deal integrating Amersham’s high throughput platforms with InforMax’s GenoMax software.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more